# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-26-300874
Filing Date
2026-07-10
Accepted
2026-07-10 16:05:14
Documents
16
Period of Report
2026-08-14

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ck0001774857-20260710.htm iXBRL | DEF 14A | 891170
2 | GRAPHIC | img37144761_0.jpg | GRAPHIC | 25798
3 | GRAPHIC | img37144761_1.jpg | GRAPHIC | 77543
4 | GRAPHIC | img37144761_2.jpg | GRAPHIC | 77543
5 | GRAPHIC | img37144761_3.jpg | GRAPHIC | 2834312
6 | GRAPHIC | img37144761_4.jpg | GRAPHIC | 2032143
| Complete submission text file | 0001193125-26-300874.txt |  | 12554769

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | ck0001774857-20260710.xsd | EX-101.SCH | 7487
21 | EXTRACTED XBRL INSTANCE DOCUMENT | ck0001774857-20260710_htm.xml | XML | 6490

Mailing Address 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122 (858) 225-7696
Aardvark Therapeutics, Inc. (Filer) CIK: 0001774857 (see all company filings)

EIN.: 821606367 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-42513 | Film No.: 261168773
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)